Remedent, Inc. Announces Launch of Exclusive Strategic Marketing Program with GlamTech USA, Inc. for the Distribution of GlamSmi
15 April 2008 - 11:00PM
Business Wire
Remedent, Inc. (OTCBB: REMI), an international company specializing
in oral care and cosmetic dentistry products, and renowned cosmetic
dentist Dr. Cyrus Tahmesebi, today announced the launch of GlamTech
USA, Inc., a strategic marketing group dedicated to making
GlamSmile� the #1 veneer system in America. The Remedent/GlamTech
alliance will significantly lessen time-to-market for the
GlamSmile� product in the world�s largest dental market while
allowing Remedent to better allocate resources to global markets,
product development, and manufacturing and distribution
enhancements. Led by CEO Dr. Tahmesebi, GlamTech brings together
substantial capital and expertise around the single goal of
dominating the domestic veneer marketplace. GlamTech will focus on
building dentist and consumer interest in GlamSmile� through trade
and consumer advertising, direct marketing, and strategic
alliances. Under the terms of a distribution agreement between the
two companies, GlamTech has exclusive rights to market and
distribute Remedent�s GlamSmile� veneers in the United States and
Canada. GlamTech�s seven-figure commitment includes a significant
license fee and agreement to purchase a sizable minimum number of
veneer trays annually. In order to maintain its exclusive
distributorship, the agreement also calls for incremental yearly
Glamsmile� veneer tray purchases of a minimum of 15% over prior
year's minimums. Dr. Tahmesebi operates cosmetic dental practices
in Southern California, is a guest lecturer at the University of
Southern California Dental School, and has appeared on numerous
television network shows on dental matters. Until recently he was
the Medical and Dental Director of BriteSmile. GlamTech President,
Roger Leddington, has 17 years experience launching innovative
dental technologies and products within domestic and international
markets. Mr. Leddington guided GlamSmile's entry into the US market
late last year and, in conjunction with the GlamTech distribution
agreement, is resigning his position as Senior Vice President and
Head of US Marketing for Remedent in order to accept the position
as GlamTech�s President. Mr. Guy De Vreese, Chairman of Remedent,
noted, �The United States is the #1 dental market in the world and
this relationship means an increased speed-to-market due to our
distributor's significant marketing capability. Our exclusive
distributorship with Dr. Tahmesebi and GlamTech creates a very
strong foundation for penetrating the US dental market and
accelerating continuing revenue streams from GlamSmile� sales
while, at the same time, providing Remedent with improved capital
structure for its global expansion and product development.�
GlamTech CEO Dr. Tahmesebi stated, �GlamSmile represents a very
exciting opportunity for every dentist and millions of consumers in
the United States and Canada. Building on Remedent�s initial
introduction of GlamSmile, GlamTech plans a broad-based advance of
that launch to educate clinicians and consumers about the very
compelling professional and personal advantages of this
extraordinary product.� About Remedent, Inc. Remedent, Inc., a
publicly-traded company on the OTCBB, specializes in the research,
development, manufacturing and marketing of oral care and cosmetic
dentistry products. With offices in California, Belgium and
Singapore, Remedent distributes its products in more than 35
countries. For additional information, visit Remedent's web site at
www.remedent.com. FORWARD-LOOKING STATEMENTS �Safe Harbor�
Statement under the Private Securities Litigation Reform Act of
1995: The statements by Guy De Vreese, the statements regarding
growth of the Glamsmile� product line, optimism related to the
business, expanding sales, the U.S. and international markets and
other statements in this press release are forward-looking
statements within the meaning of the Securities Litigation Reform
Act of 1995. Such statements are based on current expectations,
estimates and projections about the Company�s business. Words such
as expects, anticipates, intends, plans, believes, sees, estimates
and variations of such words and similar expressions are intended
to identify such forward-looking statements. These statements are
not guarantees of future performance and involve certain risks and
uncertainties that are difficult to predict. Actual results could
vary materially from the description contained herein due to many
factors including continued market acceptance of the Company�s
products. In addition, actual results could vary materially based
on changes or slower growth in the oral care and cosmetic dentistry
products market; the potential inability to realize expected
benefits and synergies; domestic and international business and
economic conditions; changes in the dental industry; unexpected
difficulties in penetrating the oral care and cosmetic dentistry
products market; changes in customer demand or ordering patterns;
changes in the competitive environment including pricing pressures
or technological changes; technological advances; shortages of
manufacturing capacity; future production variables impacting
excess inventory and other risk factors listed from time to time in
the Company�s Securities and Exchange Commission filings under
�risk factors� and elsewhere. The forward-looking statements
contained in this press release speak only as of the date on which
they are made, and the Company does not undertake any obligation to
update any forward-looking statement to reflect events or
circumstances after the date of this press release.
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Elysee Development Corp (PK) (OTCMarkets): 0 recent articles
More Remedent, Inc. News Articles